These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33249135)

  • 1. Design, synthesis, and evaluation of substrate - analogue inhibitors of Trypanosoma cruzi ribose 5-phosphate isomerase type B.
    Gonzalez SN; Mills JJ; Maugeri D; Olaya C; Laguera BL; Enders JR; Sherman J; Rodriguez A; Pierce JG; Cazzulo JJ; D'Antonio EL
    Bioorg Med Chem Lett; 2021 Jan; 32():127723. PubMed ID: 33249135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico identification of inhibitors of ribose 5-phosphate isomerase from Trypanosoma cruzi using ligand and structure based approaches.
    de V C Sinatti V; R Baptista LP; Alves-Ferreira M; Dardenne L; Hermínio Martins da Silva J; Guimarães AC
    J Mol Graph Model; 2017 Oct; 77():168-180. PubMed ID: 28865321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribose 5-phosphate isomerase type B from Trypanosoma cruzi: kinetic properties and site-directed mutagenesis reveal information about the reaction mechanism.
    Stern AL; Burgos E; Salmon L; Cazzulo JJ
    Biochem J; 2007 Jan; 401(1):279-85. PubMed ID: 16981853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based approach to the identification of a novel group of selective glucosamine analogue inhibitors of Trypanosoma cruzi glucokinase.
    D'Antonio EL; Deinema MS; Kearns SP; Frey TA; Tanghe S; Perry K; Roy TA; Gracz HS; Rodriguez A; D'Antonio J
    Mol Biochem Parasitol; 2015 Dec; 204(2):64-76. PubMed ID: 26778112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of type B ribose 5-phosphate isomerase from Trypanosoma cruzi shed light on the determinants of sugar specificity in the structural family.
    Stern AL; Naworyta A; Cazzulo JJ; Mowbray SL
    FEBS J; 2011 Mar; 278(5):793-808. PubMed ID: 21205211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying effects of different protonation states of His11 and His102 in ribose-5-phosphate isomerase of
    Soares RF; Antunes D; Santos LHS; Rocha GV; Bastos LS; Guimarães ACR; Caffarena ER
    J Biomol Struct Dyn; 2020 Apr; 38(7):2047-2056. PubMed ID: 31184542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, molecular modelling, and in vitro evaluation of tricyclic coumarins against Trypanosoma cruzi.
    Coelho GS; Andrade JS; Xavier VF; Sales Junior PA; Rodrigues de Araujo BC; Fonseca KDS; Caetano MS; Murta SMF; Vieira PM; Carneiro CM; Taylor JG
    Chem Biol Drug Des; 2019 Mar; 93(3):337-350. PubMed ID: 30362274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of methods in cheminformatics and biocalorimetry for the design of trypanosomatid enzyme inhibitors.
    Prokopczyk IM; Ribeiro JF; Sartori GR; Sesti-Costa R; Silva JS; Freitas RF; Leitão A; Montanari CA
    Future Med Chem; 2014 Jan; 6(1):17-33. PubMed ID: 24358945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Virtual Screening and In Vitro Evaluation of New
    Herrera-Mayorga V; Lara-Ramírez EE; Chacón-Vargas KF; Aguirre-Alvarado C; Rodríguez-Páez L; Alcántara-Farfán V; Cordero-Martínez J; Nogueda-Torres B; Reyes-Espinosa F; Bocanegra-García V; Rivera G
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
    Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
    J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a novel Ribose 5-phosphate isomerase B from Leishmania donovani.
    Kaur PK; Dinesh N; Soumya N; Babu NK; Singh S
    Biochem Biophys Res Commun; 2012 Apr; 421(1):51-6. PubMed ID: 22483752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
    Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
    Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity.
    Aguilera E; Varela J; Birriel E; Serna E; Torres S; Yaluff G; de Bilbao NV; Aguirre-López B; Cabrera N; Díaz Mazariegos S; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Minini L; Merlino A; Cerecetto H; González M; Alvarez G
    ChemMedChem; 2016 Jun; 11(12):1328-38. PubMed ID: 26492824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.
    Álvarez G; Martínez J; Varela J; Birriel E; Cruces E; Gabay M; Leal SM; Escobar P; Aguirre-López B; Cabrera N; Tuena de Gómez-Puyou M; Gómez Puyou A; Pérez-Montfort R; Yaluff G; Torres S; Serna E; Vera de Bilbao N; González M; Cerecetto H
    Eur J Med Chem; 2015 Jul; 100():246-56. PubMed ID: 26094151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi.
    Freymann DM; Wenck MA; Engel JC; Feng J; Focia PJ; Eakin AE; Craig SP
    Chem Biol; 2000 Dec; 7(12):957-68. PubMed ID: 11137818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribose 5-phosphate isomerase B knockdown compromises Trypanosoma brucei bloodstream form infectivity.
    Loureiro I; Faria J; Clayton C; Macedo-Ribeiro S; Santarém N; Roy N; Cordeiro-da-Siva A; Tavares J
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e3430. PubMed ID: 25568941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents.
    Ferreira RS; Dessoy MA; Pauli I; Souza ML; Krogh R; Sales AI; Oliva G; Dias LC; Andricopulo AD
    J Med Chem; 2014 Mar; 57(6):2380-92. PubMed ID: 24533839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol inhibits Trypanosoma cruzi arginine kinase and exerts a trypanocidal activity.
    Valera Vera EA; Sayé M; Reigada C; Damasceno FS; Silber AM; Miranda MR; Pereira CA
    Int J Biol Macromol; 2016 Jun; 87():498-503. PubMed ID: 26976067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biochemical, and biological evaluation of C2 linkage derivatives of amino sugars, inhibitors of glucokinase from Trypanosoma cruzi.
    Green SB; Lanier RJ; Carey SM; Morgan DR; Gracz H; Sherman J; Rodriguez A; D'Antonio EL
    Bioorg Med Chem Lett; 2021 Sep; 47():128227. PubMed ID: 34174398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors.
    Avelar LA; Camilo CD; de Albuquerque S; Fernandes WB; Gonçalez C; Kenny PW; Leitão A; McKerrow JH; Montanari CA; Orozco EV; Ribeiro JF; Rocha JR; Rosini F; Saidel ME
    PLoS Negl Trop Dis; 2015; 9(7):e0003916. PubMed ID: 26173110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.